Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.233 USD | -1.36% | +4.49% | -34.41% |
May. 15 | HC Wainwright Adjusts IO Biotech Price Target to $12 From $8, Maintains Buy Rating | MT |
May. 14 | IO Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar IO Biotech, Inc.
Upcoming events on IO Biotech, Inc.
Past events on IO Biotech, Inc.
2024-06-05 07:30 am | Jefferies Global Healthcare Conference |
2024-06-01 10:00 am | American Society of Clinical Oncology Meeting - Abstract No TPS2701 |
2024-05-12 | Q1 2024 Earnings Release (Projected) |
2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Abstract No : 4094 |
2024-03-06 12:50 pm | TD Cowen Health Care Conference |
2024-03-05 04:40 pm | Q4 2023 Earnings Release |
2023-11-29 04:30 pm | Piper Sandler Healthcare Conference |
2023-11-14 | Jefferies London Healthcare Conference |
2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number : 1468 |
2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number : 1335 |
2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number : 1029 |
2023-10-23 03:00 am | European Society for Medical Oncology Congress - Poster No:1038P |
2023-10-19 | ESMO Congress - Poster Number: 1038P |
2023-09-13 02:00 pm | H.C. Wainwright Global Investment Conference |
2023-09-12 04:15 pm | Morgan Stanley Global Healthcare Conference |
2023-09-11 10:45 pm | IASLC World Conference |
2023-08-11 08:30 am | Q2 2023 Earnings Release |
2023-06-08 08:30 am | Annual General Meeting |
2023-06-07 12:30 pm | Jefferies Global Healthcare Conference |
2023-05-11 04:05 pm | Q1 2023 Earnings Release |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -41,2 -67,0 38.45% | 0,00 0,00 - | -91,4 -81,1 -12.61% | -95 892 |
EBIT Million USD | Released Forecast Spread | 0,00 | -41,2 -49,0 15.79% | -71,4 -68,6 -4.17% | -91,4 -88,1 -3.78% | -87,1 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -67,8 -57,9 -17.17% | -70,7 -68,5 -3.19% | -85,2 -82,8 -2.99% | -84,0 |
Net income Million USD | Released Forecast Spread | -14,6 | -75,0 -58,4 -28.29% | -71,3 -68,7 -3.89% | -86,1 -83,1 -3.55% | -84,4 |
EPS USD | Released Forecast Spread | -82,4 | -17,3 -11,4 -51.49% | -2,48 -2,37 -4.79% | -1,98 -2,03 2.58% | -1,40 |
Announcement Date | 09/08/21 | 31/03/22 | 14/03/23 | 05/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -17,0 -14,0 -21.5% | -18,2 -12,0 -51.34% | -15,9 -16,5 3.57% | -20,4 -17,2 -18.83% | -17,9 -20,9 14.03% | -21,9 -20,6 -6.21% | -23,5 -23,4 -0.36% | -28,2 -24,9 -13.39% | -20,2 -24,5 17.68% | -21,2 | -22,3 | -23,4 | -31,3 | -32,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,1 -14,0 -22.41% | -18,4 -12,0 -53.26% | -15,6 -16,5 5.39% | -19,6 -17,1 -14.9% | -16,6 -19,6 15.11% | -20,6 -20,0 -3.23% | -22,1 -21,3 -3.72% | -25,8 -23,4 -10.58% | -19,0 -23,1 17.5% | -20,3 | -21,6 | -23,0 | -28,9 | -29,9 |
Net income Million USD | Released Forecast Spread | -17,2 -14,0 -22.89% | -18,5 -12,0 -54.13% | -15,7 -16,5 4.69% | -19,9 -17,1 -16.82% | -17,0 -19,6 13.04% | -21,2 -20,0 -5.89% | -21,7 -21,3 -1.66% | -26,2 -23,4 -12.09% | -19,5 -23,1 15.7% | -20,3 | -21,6 | -23,0 | -28,9 | -29,9 |
EPS USD | Released Forecast Spread | -0,60 -0,50 -20% | -0,64 -0,40 -60% | -0,54 -0,56 3.57% | -0,69 -0,61 -13.74% | -0,59 -0,68 13.24% | -0,74 -0,67 -10.45% | -0,43 -0,33 -31.63% | -0,40 -0,39 -3.9% | -0,30 -0,35 13.46% | -0,31 | -0,33 | -0,35 | -0,26 | -0,27 |
Announcement Date | 16/05/22 | 11/08/22 | 09/11/22 | 14/03/23 | 11/05/23 | 11/08/23 | 13/11/23 | 05/03/24 | 14/05/24 | - | - | - | - | - |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for IO Biotech, Inc.
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IOBT Stock
- Calendar IO Biotech, Inc.